Synthesis and Development of Indole Based 5-HT3 Receptor Antagonists as Anti-Emetic Drugs in Oncology :An Update

被引：2

作者：

Rivera-Fonseca, Johana L. ^{[1
,2
]}

Gonzalez-Rivas, Nelly ^{[1
,2
]}

Basavanag Unnamatla, M., V ^{[1
,2
]}

Garcia-Eleno, Marco A. ^{[1
,2
]}

Reyes, Horacio ^{[3
]}

German Lopez-Valdez, L. ^{[4
]}

Corona-Becerril, David ^{[1
,2
]}

Cuevas-Yanez, Erick ^{[1
,2
]}

机构：

[1] UAEM UNAM, Ctr Conjunto Invest Quim Sustentable, Carretera Toluca Atlacomulco Km 14-5, Toluca 50200, Estado De Mexic, Mexico

[2] Univ Autonoma Estado Mexico, Fac Quim, Toluca 50120, Mexico

[3] Tecnol Estudios Super Jocotitlan, Div Ingn Quim, Carretera Toluca Atlacomulco Km 44-8, Jocotitlan, Edo, Mexico

[4] Univ Autonoma Chapingo, Dept Preparatoria Agr, Area Quim, Lab Prod Nat, Apartado 74,Km 38-5 Carretera Mexico Texcoco, Chapingo 56230, Mexico

来源：

CURRENT MEDICINAL CHEMISTRY | 2021年 / 28卷 / 42期

关键词：

Antiemetic drugs; 5-HT3; indole; synthesis; ondansetron; ramosetron; dolasetron; granisetron; ricaset-ron; tropisetron; CHEMOTHERAPY-INDUCED NAUSEA; IRRITABLE-BOWEL-SYNDROME; INDUCED EMESIS; 5-HYDROXYTRYPTAMINE(3) RECEPTORS; PHARMACOLOGICAL PROFILE; POSTOPERATIVE NAUSEA; ANTICIPATORY NAUSEA; THERAPEUTIC AGENT; CHRONIC TOXICITY; VOMITING CINV;

D O I：

10.2174/0929867328666210708091134

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

An important group of antiemetic drugs used in the treatment of nausea and vomiting after chemotherapy containing an indole moiety in their structures, working as 5hydroxytryptamine type 3 serotonin receptor antagonist (5-HT3). This study focuses on compounds bearing an indole core that present a 5-HT3 receptor antagonist activity, which have been successfully used as antiemetic drugs for reducing chemotherapy adverse secondary effects during cancer treatment. Their synthesis, biological activities, and some outstanding characteristics are discussed, providing a general outlook towards the development of more efficient antiemetic drugs.

引用

页码：8733 / 8754

页数：22

共 50 条

[31] Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists
Wolf, H
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2000, 29 : 37 - 45
[32] Spectrum of use and tolerability of 5-HT3 receptor antagonists
Haus, U
Späth, M
Färber, L
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2004, 33 : 12 - 18
[33] 5-HT3 receptor antagonists for the treatment of nausea/vomiting
Smith, Howard S.
Cox, Lorraine R.
Smith, Eric J.
ANNALS OF PALLIATIVE MEDICINE, 2012, 1 (02) : 115 - 120
[34] THE ECONOMIC-IMPACT OF 5-HT3 RECEPTOR ANTAGONISTS
CUNNINGHAM, K
HIRSCH, J
FREEMAN, A
EUROPEAN JOURNAL OF CANCER, 1993, 29A (06) : 930 - 930
[35] Investigation of HTR3C mutations for association with 5HT3 receptor antagonist anti-emetic efficacy
Ward, Michael B.
Kotasek, Dusan
McKinnon, Ross A.
PHARMACOGENOMICS, 2008, 9 (08) : 1027 - 1033
[36] Nonsteroidal Anti-inflammatory Drugs and 5-HT3 Serotonin Receptor Antagonists as Innovative Antipsychotic Augmentation Treatments for Schizophrenia
Andrade, Chittaranjan
JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (07) : E707 - E709
[37] 5-HT3 RECEPTOR AGONISM MAY BE RESPONSIBLE FOR THE EMETIC EFFECTS OF ZACOPRIDE IN THE FERRET
MIDDLEFELL, VC
PRICE, TL
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (01) : 1011 - 1012
[38] SELECTIVITY OF 5-HT3 RECEPTOR ANTAGONISTS AND ANTIEMETIC MECHANISMS OF ACTION
FREEMAN, AJ
CUNNINGHAM, KT
TYERS, MB
ANTI-CANCER DRUGS, 1992, 3 (02) : 79 - 85
[39] 5-HT3 RECEPTOR ANTAGONISTS REVERSE HELPLESS BEHAVIOR IN RATS
MARTIN, P
GOZLAN, H
PUECH, AJ
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 212 (01) : 73 - 78
[40] PHARMACOLOGICAL PROPERTIES OF A NOVEL CLASS OF 5-HT3 RECEPTOR ANTAGONISTS
TURCONI, M
DONETTI, A
SCHIAVONE, A
SAGRADA, A
MONTAGNA, E
NICOLA, M
CESANA, R
RIZZI, C
MICHELETTI, R
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 203 (02) : 203 - 211

← 1 2 3 4 5 →